Neal Gordon Simon
Fundador en Azevan Pharmaceuticals, Inc. .
Cargos activos de Neal Gordon Simon
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
Azevan Pharmaceuticals, Inc.
 Azevan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Azevan Pharmaceuticals, Inc. develops novel therapeutics to treat disorders of stress, mood, and behavior. Its first clinical compounds selectively block the effects of arginine vasopressin, a peptide neurohormone involved in the pathophysiology of neuropsychiatric symptoms in neurodegenerative diseases and a broad range of stress-related affective disorders, including Post-traumatic Stress Disorder (PTSD), Intermittent Explosive Disorder, and major depression. The company was founded by Craig F. Ferris and Neal Gordon Simon in 1999 and is headquartered in Bethlehem. | Director/Miembro de la Junta | 15/12/2010 | - |
| Director Ejecutivo | 01/01/1999 | - | |
| Fundador | 01/01/1999 | - |
Historial de carrera de Neal Gordon Simon
Antiguos cargos conocidos de Neal Gordon Simon.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| University of Strasbourg | Corporate Officer/Principal | 01/01/1996 | - |
| Lehigh University | Corporate Officer/Principal | - | - |
Formación de Neal Gordon Simon.
| Rutgers State University of New Jersey | Doctorate Degree |
| State University of New York at Binghamton | Undergraduate Degree |
Estadísticas
Internacional
| Estados Unidos | 5 |
| Francia | 2 |
Operativa
| Corporate Officer/Principal | 2 |
| Director/Board Member | 1 |
| Chief Executive Officer | 1 |
Sectorial
| Consumer Services | 5 |
| Health Technology | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
Azevan Pharmaceuticals, Inc.
Azevan Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Azevan Pharmaceuticals, Inc. develops novel therapeutics to treat disorders of stress, mood, and behavior. Its first clinical compounds selectively block the effects of arginine vasopressin, a peptide neurohormone involved in the pathophysiology of neuropsychiatric symptoms in neurodegenerative diseases and a broad range of stress-related affective disorders, including Post-traumatic Stress Disorder (PTSD), Intermittent Explosive Disorder, and major depression. The company was founded by Craig F. Ferris and Neal Gordon Simon in 1999 and is headquartered in Bethlehem. | Health Technology |
- Bolsa de valores
- Insiders
- Neal Gordon Simon
- Experiencia
